Immunohistochemistry, RT-qPCR, and Western blot analysis confirmed downregulated expression of IL-38 in the skin lesions of the AD model (Figure 1C-E), consistent with the findings in AD patients (Figure 1B). Here, IL1F10 is linked to Alzheimer disease.